Structure of the N-terminal domain of human thioredoxin-interacting protein

被引:21
|
作者
Polekhina, Galina [1 ]
Ascher, David Benjamin [2 ]
Kok, Shie Foong [1 ]
Beckham, Simone [1 ,3 ]
Wilce, Matthew [3 ]
Waltham, Mark [2 ]
机构
[1] Monash Univ, Ctr Canc Res, Monash Inst Med Res, Clayton, Vic 3168, Australia
[2] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia
[3] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia
基金
澳大利亚国家健康与医学研究理事会; 澳大利亚研究理事会; 英国医学研究理事会;
关键词
thioredoxin-interacting protein; arrestins; diabetes; metabolism; glucose uptake; UP-REGULATED PROTEIN-1; OXIDATIVE STRESS; CRYSTAL-STRUCTURE; RECEPTOR-BINDING; VISUAL ARRESTIN; GLUCOSE; VDUP1; TXNIP; EXPRESSION; CANCER;
D O I
10.1107/S0907444912047099
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Thioredoxin-interacting protein (TXNIP) is one of the six known -arrestins and has recently received considerable attention owing to its involvement in redox signalling and metabolism. Various stress stimuli such as high glucose, heat shock, UV, H2O2 and mechanical stress among others robustly induce the expression of TXNIP, resulting in the sequestration and inactivation of thioredoxin, which in turn leads to cellular oxidative stress. While TXNIP is the only -arrestin known to bind thioredoxin, TXNIP and two other -arrestins, Arrdc4 and Arrdc3, have been implicated in metabolism. Furthermore, owing to its roles in the pathologies of diabetes and cardiovascular disease, TXNIP is considered to be a promising drug target. Based on their amino-acid sequences, TXNIP and the other -arrestins are remotely related to -arrestins. Here, the crystal structure of the N-terminal domain of TXNIP is reported. It provides the first structural information on any of the -arrestins and reveals that although TXNIP adopts a -arrestin fold as predicted, it is structurally more similar to Vps26 proteins than to -arrestins, while sharing below 15% pairwise sequence identity with either.
引用
收藏
页码:333 / 344
页数:12
相关论文
共 50 条
  • [41] Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis
    Duan, Jialiang
    Du, Chunyang
    Shi, Yonghong
    Liu, Danyan
    Ma, Jingxue
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2018, 94 : 61 - 70
  • [42] Thioredoxin-interacting protein (Txnip): more than its name
    Ma, Yonggang
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2021, 321 (02): : H257 - H258
  • [43] Role of thioredoxin-interacting protein in mediating endothelial dysfunction in hypertension
    Wang, Ruiyu
    Guo, Yongzheng
    Li, Lingjiao
    Luo, Minghao
    Peng, Linqian
    Lv, Dingyi
    Cheng, Zhe
    Xue, Qian
    Wang, Liang
    Huang, Jing
    GENES & DISEASES, 2022, 9 (03) : 753 - 765
  • [44] Thioredoxin-Interacting Protein: A Novel Therapeutic Target for Diabetic Cardiomyopathy
    Chen, Junqin
    Cha-Molstad, Hyunjoo
    Shalev, Anath
    DIABETES, 2009, 58 : A208 - A208
  • [45] Structure and function of the N-terminal domain of the human mitochondrial calcium uniporter
    Lee, Youngjin
    Min, Choon Kee
    Kim, Tae Gyun
    Song, Hong Ki
    Lim, Yunki
    Kim, Dongwook
    Shin, Kahee
    Kang, Moonkyung
    Kang, Jung Youn
    Youn, Hyung-Seop
    Lee, Jung-Gyu
    An, Jun Yop
    Park, Kyoung Ryoung
    Lim, Jia Jia
    Kim, Ji Hun
    Kim, Ji Hye
    Park, Zee Yong
    Kim, Yeon-Soo
    Wang, Jimin
    Kim, Do Han
    Eom, Soo Hyun
    EMBO REPORTS, 2015, 16 (10) : 1318 - 1333
  • [46] Electrostatic interactions in the active site of the N-terminal thioredoxin-like domain of protein disulfide isomerase
    Kortemme, T
    Darby, NJ
    Creighton, TE
    BIOCHEMISTRY, 1996, 35 (46) : 14503 - 14511
  • [47] Gene expression of thioredoxin-interacting protein is upregulated by glucose in human prostatic carcinoma cells.
    Shie, Wen-Chi
    Pang, See-Tong
    Lin, Chang-Mei
    Lin, Han-Tze
    Juang, Horng-Heng
    BIOLOGY OF REPRODUCTION, 2006, : 150 - 150
  • [48] Overview on Thioredoxin-Interacting Protein (TXNIP): A Potential Target for Diabetes Intervention
    Basnet, Rajesh
    Basnet, Til Bahadur
    Basnet, Buddha Bahadur
    Khadka, Sandhya
    CURRENT DRUG TARGETS, 2022, 23 (07) : 761 - 767
  • [49] Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and Neurodegenerative Diseases: Regulation and Implication
    Nasoohi, Sanaz
    Ismael, Saifudeen
    Ishrat, Tauheed
    MOLECULAR NEUROBIOLOGY, 2018, 55 (10) : 7900 - 7920
  • [50] Thioredoxin-Interacting Protein: Pathophysiology and Emerging Pharmacotherapeutics in Cardiovascular Disease and Diabetes
    Chong, Cher-Rin
    Chan, Wai Ping A.
    Nguyen, Thanh H.
    Liu, Saifei
    Procter, Nathan E. K.
    Ngo, Doan T.
    Sverdlov, Aaron L.
    Chirkov, Yuliy Y.
    Horowitz, John D.
    CARDIOVASCULAR DRUGS AND THERAPY, 2014, 28 (04) : 347 - 360